Merus N.V.

DB:2GH Stock Report

Market Cap: €2.8b

Merus Management

Management criteria checks 3/4

Merus' CEO is Bill Lundberg, appointed in Dec 2019, has a tenure of 5.5 years. total yearly compensation is $4.67M, comprised of 13.9% salary and 86.1% bonuses, including company stock and options. directly owns 0.22% of the company’s shares, worth €6.20M. The average tenure of the management team and the board of directors is 2.9 years and 6.3 years respectively.

Key information

Bill Lundberg

Chief executive officer

US$4.7m

Total compensation

CEO salary percentage13.9%
CEO tenure5yrs
CEO ownership0.2%
Management average tenure2.9yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bill Lundberg's remuneration changed compared to Merus's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$245m

Jun 30 2024n/an/a

-US$168m

Mar 31 2024n/an/a

-US$150m

Dec 31 2023US$5mUS$650k

-US$155m

Sep 30 2023n/an/a

-US$177m

Jun 30 2023n/an/a

-US$178m

Mar 31 2023n/an/a

-US$152m

Dec 31 2022US$6mUS$599k

-US$131m

Sep 30 2022n/an/a

-US$64m

Jun 30 2022n/an/a

-US$54m

Mar 31 2022n/an/a

-US$76m

Dec 31 2021US$8mUS$582k

-US$67m

Sep 30 2021n/an/a

-US$80m

Jun 30 2021n/an/a

-US$89m

Mar 31 2021n/an/a

-US$79m

Dec 31 2020US$5mUS$565k

-US$86m

Sep 30 2020n/an/a

-US$83m

Jun 30 2020n/an/a

-US$69m

Mar 31 2020n/an/a

-US$65m

Dec 31 2019US$162kn/a

-US$55m

Compensation vs Market: Bill's total compensation ($USD4.67M) is above average for companies of similar size in the German market ($USD1.93M).

Compensation vs Earnings: Bill's compensation has been consistent with company performance over the past year.

CEO

Bill Lundberg (61 yo)

5yrs

Tenure

US$4,671,327

Compensation

Dr. Sven Ante Lundberg, also known as Bill, M.D. is Venture Advisor of Forge Life Science Partners. He serves as Chief Executive Officer, President and Executive Director of Merus N.V. since December 31, 2...

Leadership Team

NamePositionTenureCompensationOwnership
Sven Lundberg
CEO, President & Executive Director5yrsUS$4.67m0.22%
€ 6.2m
Gregory Perry
Chief Financial Officer1.5yrsUS$6.21m0%
€ 0
Peter Silverman
EVP, Company Secretary6.8yrsUS$1.95mno data
Hennie Hoogenboom
Co-Founder and Scientific Advisorno datano datano data
Harry Shuman
Chief Accounting Officerno datano data0.010%
€ 285.7k
Cornelis de Kruif
CTO & Executive VP11.9yrsUS$609.22kno data
Cecilia Anna Geuijen
Chief Scientific Officer & Senior VP3.6yrsno datano data
Kathleen Farren
IR & Corporate Communications Officerno datano datano data
Audrey Bergan
Chief People Officerless than a yearno datano data
Shannon Campbell
Executive VP & Chief Commercial Officer2.8yrsno datano data
Ashley Pereira
Senior Vice President of Regulatory Affairs2.9yrsno datano data
Ernesto Wasserman
Senior Vice President of Clinical Development2.9yrsno datano data

2.9yrs

Average Tenure

59yo

Average Age

Experienced Management: 2GH's management team is considered experienced (2.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sven Lundberg
CEO, President & Executive Director5.5yrsUS$4.67m0.22%
€ 6.2m
Elaine Jones
Board Observer14.9yrsno datano data
Maxine Gowen
Independent Non-Executive Director3.6yrsUS$305.06k0%
€ 0
Anand Mehra
Independent Chairman9.3yrsUS$417.56k0%
€ 0
Paolo Pucci
Independent Non-Executive Director4.5yrsUS$309.56k0%
€ 0
Mark Iwicki
Independent Non Executive Director9.5yrsUS$311.06k0.11%
€ 3.0m
Antoni Ribas
Member of Scientific Advisory Board6.3yrsno datano data
Victor Sandor
Independent Non-Executive Director5.5yrsUS$303.56k0%
€ 0
Josep Tabernero Caturla
Member of Scientific Advisory Board6.3yrsno datano data
Antonius Schumacher
Member of Scientific Advisory Board6.3yrsno datano data
Jason Haddock
Independent Non-Executive Directorless than a yearno datano data
Len Kanavy
Independent Non-Executive Director6.4yrsUS$303.56k0%
€ 0

6.3yrs

Average Tenure

59.5yo

Average Age

Experienced Board: 2GH's board of directors are considered experienced (6.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 05:03
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Merus N.V. is covered by 22 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Etzer DaroutBMO Capital Markets Equity Research
Evan SeigermanBMO Capital Markets Equity Research
Tazeen AhmadBofA Global Research